Related references
Note: Only part of the references are listed.Modulating the NO generating system from a medicinal chemistry perspective: Current trends and therapeutic options in cardiovascular disease
Dennis Schade et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Nδ-Methylated L-arginine derivatives and their effects on the nitric oxide generating system
Juerke Kotthaus et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Structure-activity relationship of novel and known inhibitors of human dimethylarginine dimethylaminohydrolase-1: Alkenyl-amidines as new leads
Juerke Kotthaus et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
The Fourth Molybdenum Containing Enzyme mARC: Cloning and Involvement in the Activation of N-Hydroxylated Prodrugs
Sanja Gruenewald et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Synthetic approaches to Nδ-methylated L-arginine, Nω-hydroxy-L-arginine, L-citrulline, and Nδ-cyano-L-ornithine
Dennis Schade et al.
JOURNAL OF ORGANIC CHEMISTRY (2008)
Arginase: A critical regulator of nitric oxide synthesis and vascular function
William Durante et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function
Arturo J. Cardounel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Identification of the missing component in the mitochondrial benzamidoxime prodrug-converting system as a novel molybdenum enzyme
Antje Havemeyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Reduction of Nω-hydroxy-L-arginine to L-arginine by pig liver microsomes, mitochondria, and human liver microsomes
Bernd Clement et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
L-arginine supplementation or arginase inhibition augments reflex cutaneous vasodilatation in aged human skin
Lacy A. Holowatz et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
How to control NO production in cells: N-omega,N-omega-dimethyl-L-arginine dimethylaminohydrolase as a novel drug target
Markus Knipp
CHEMBIOCHEM (2006)
Hepatic, extrahepatic, microsomal, and mitochondrial activation of the N-hydroxylated prodrugs benzamidoxime, guanoxabenz, and RO 48-3656 ([[1-[(2S)-2-[[4-[(hydroxyamino)iminomethyl]benzoyl]amino]-1-oxopropyl]-4-piperidinyl]oxy]-acetic acid)
B Clement et al.
DRUG METABOLISM AND DISPOSITION (2005)
Mitochondrial nitric oxide synthase
P Ghafourifar et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans
JR Kurian et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Nitric oxide synthase activity in rat cardiac mitochondria
B Zanella et al.
BASIC RESEARCH IN CARDIOLOGY (2004)
Proteomic analysis of the mouse liver mitochondrial inner membrane
S Da Cruz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The antioxidants of legume nodule mitochondria
I Iturbe-Ormaetxe et al.
MOLECULAR PLANT-MICROBE INTERACTIONS (2001)
Molybdenum metabolism: Stable isotope studies in infancy
E Sievers et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2001)
Share Paper
